<document page-count="7">
<page number="1">
<table data-filename="06.INFLUENCE OF MELATONIN ON THE ACTIVITY OF MAIN ENZYMES.pdf" data-page="1" data-table="1"><tr><td>Archives of the Balkan Medical Union</td><td>vol. 54, no. 2, pp. 260-266</td></tr><tr><td>Copyright © 2019 Balkan Medical Union</td><td>June 2019</td></tr><tr><td></td><td>ORIGINAL PAPER</td></tr><tr><td colspan="2">INFLUENCE OF MELATONIN ON THE ACTIVITY OF MAIN</td></tr><tr><td colspan="2">ENZYMES OF CORI CYCLE IN SKELETAL MUSCLES,</td></tr><tr><td colspan="2">HEART, LIVER AND KIDNEYS OF ALLOXAN-INDUCED</td></tr><tr><td>DIABETIC RATS</td><td></td></tr><tr><td>Oleksandra Yu. KUSHNIR 1</td><td>, Iryna M. YAREMII 1 , Inna G. KYSHKAN 1 , Kyrylo A. PANTSIUK 1 ,</td></tr><tr><td>Iryna D. VIZNIUK 1</td><td></td></tr><tr><td colspan="2">1Higher State Educational Establishment of Ukraine “Bukovinian State Medical University“, Chernivtsi,</td></tr><tr><td>Ukraine</td><td></td></tr><tr><td></td><td>Received 5 Febr 2019, Accepted 14 Apr 2019</td></tr><tr><td></td><td>https://doi.org/10.31688/ABMU.2019.54.2.06</td></tr><tr><td>A BSTRACT</td><td>R ÉSUMÉ</td></tr><tr><td>Introduction. Melatonin, a potent antioxidant agent,</td><td>L’influence de la mélatonine sur l’activité des en-</td></tr><tr><td>is essential for glucose homeostasis.</td><td>zymes principales du cycle de Cori dans les muscles</td></tr><tr><td>The objective of the studywas to determine the</td><td>du squelette, le coeur, le foie et les reins de rats avec</td></tr><tr><td>influence of melatonin on basal levels of glucose in</td><td>diabète induit par l’alloxane</td></tr><tr><td>blood, activities of glucose-6-phosphatase in kidney</td><td></td></tr><tr><td>and liver, pyruvate kinase in muscles and heart, con-</td><td>Introduction. La mélatonine, un puissant agent an-</td></tr><tr><td>tent of glycogen in muscles and heart of rats with allox-</td><td>tioxydant, est essentielle à l’homéostasie et à la régula-</td></tr><tr><td>an-induced diabetes.</td><td>tion du glucose.</td></tr><tr><td>Materials and methods. Diabetes was induced in</td><td>L’objectif de l’étude a été de déterminer l’influence</td></tr><tr><td>male Wistar rats by single intraperitoneal injection of</td><td>de la mélatonine sur les taux basaux de glucose dans le</td></tr><tr><td>alloxan monohydrates (170 mg/kg). Four days after di-</td><td>sang, les activités de la glucose-6-phosphatase dans les</td></tr><tr><td>abetes induction, rats were divided into diabetic and</td><td>reins et le foie, la pyruvate-kinase dans les muscles et</td></tr><tr><td>melatonin-diabetic groups (10 mg/kg «Sigma» USA,</td><td>le cœur, la teneur en glycogène dans les muscles et le</td></tr><tr><td>daily and intraperitoneal for 14 days starting from the</td><td>cœur de rats diabétiques à l’alloxane.</td></tr><tr><td>5th day).</td><td>Matériaux et méthodes. Le diabète a été provoqué</td></tr><tr><td>Results. Melatonin injections caused normalization</td><td>chez des rats Wistar mâles par voie intrapéritonéale</td></tr><tr><td>of the elevated serum glucose level in diabetic group</td><td>avec une injection unique d’alloxane (170 mg / kg).</td></tr><tr><td>of rats compared with basal glucose level before treat-</td><td>Quatre jours après l’induction du diabète, les rats ont</td></tr><tr><td>ment. The activity of pyruvate kinase in muscle and</td><td>été divisés en groupes diabétique et diabétique à la mé-</td></tr><tr><td>heart tissue of diabetic animals was 45% and 63%</td><td>latonine (10 mg / kg «Sigma» USA, quotidiennement</td></tr><tr><td>Address for correspondence:</td><td>Oleksandra Yu. KUSHNIR</td></tr><tr><td colspan="2">Department of Bioorganic and biological chemistry and clinical biochemistry</td></tr><tr><td colspan="2">of the Higher State Educational Establishment of Ukraine</td></tr><tr><td colspan="2">„Bukovinian State Medical University “, Ukraine</td></tr><tr><td colspan="2">Address: Teatralna Sq. 2, Chernivtsi, 58002, Ukraine</td></tr><tr><td colspan="2">E-mail: kushnir@bsmu.edu.ua; Phone +380954484722</td></tr></table></page>
<page number="2">
<table data-filename="06.INFLUENCE OF MELATONIN ON THE ACTIVITY OF MAIN ENZYMES.pdf" data-page="2" data-table="1"><tr><td></td><td>Archives of the Balkan Medical Union</td></tr><tr><td>less than in control groups, respectively. Regarding</td><td>et par voie parentérale pendant 14 jours à partir du</td></tr><tr><td>kidney and liver of diabetic rats, the activity of glu-</td><td>5ème jour).</td></tr><tr><td>cose-6-phosphatase was increased in average by 148%</td><td>Résultats. Les injections de mélatonine ont entraîné</td></tr><tr><td>compared with control value. The glycogen content in</td><td>une normalisation de la glycémie élevée chez les rats</td></tr><tr><td>the heart and skeleton muscles of diabetic animals was</td><td>diabétiques par rapport à la glycémie avant le traite-</td></tr><tr><td>reduced in average by 20% compared with the control.</td><td>ment. L’activité de la pyruvate-kinase dans les tissus</td></tr><tr><td>Melatonin restored all these indexes back to normal</td><td>musculaires et cardiaques des animaux diabétiques est</td></tr><tr><td>level.</td><td>inférieure de 45% et 63% inférieure à celle du groupe</td></tr><tr><td>Conclusions.These findings suggested that mela-</td><td>témoin. Selon les résultats obtenus dans les reins et le</td></tr><tr><td>tonin restored the events in Cori cycle by possible ac-</td><td>foie de rats diabétiques, l’activité de la glucose-6-phos-</td></tr><tr><td>tivation of glycolysis in skeletal and heart muscles and</td><td>phatase a été augmentée en moyenne de 148% par</td></tr><tr><td>normalization of gluconeogenesis in liver and kidneys.</td><td>rapport à la valeur du contrôle. Nous avons constaté</td></tr><tr><td></td><td>une réduction de 20% de la teneur en glycogène dans</td></tr><tr><td>Keywords: alloxan-induced diabetes mellitus, mela-</td><td>le cœur et les muscles des animaux diabétiques par</td></tr><tr><td>tonin, carbohydrate metabolism.</td><td>rapport au témoin. La mélatonine a restauré tous ces</td></tr><tr><td></td><td>indices au niveau normal.</td></tr><tr><td>Abbreviations: BG – basal glucose, G-6-Ph-ase – glu-</td><td>Conclusions. Ces résultats suggèrent que la mélato-</td></tr><tr><td>cose-6-phosphatase, PK – pyruvate kinase, DM – dia-</td><td>nine a restauré les événements du cycle de Cori par</td></tr><tr><td>betes mellitus.</td><td>l’activation possible de la glycolyse dans les muscles</td></tr><tr><td></td><td>squelettiques et cardiaques et la normalisation de la</td></tr><tr><td></td><td>gluconéogenèse dans le foie et les reins.</td></tr><tr><td></td><td>Mots-clés: diabète sucré induit par l’alloxane, méla-</td></tr><tr><td></td><td>tonine, métabolisme des glucides.</td></tr><tr><td>I NTRODUCTION</td><td>tissue involved in maintaining glucose homeostasis</td></tr><tr><td></td><td>under insulin-stimulated conditions. Type 1 diabetic</td></tr><tr><td>Microvascular and macrovascular complications</td><td>subjects without insulin treatment display a dramatic</td></tr><tr><td>are the leading causes of morbidity and mortality in</td><td>loss of muscle, which leads to higher blood glucose</td></tr><tr><td>diabetic patients1. Hyperglycemia can increase the in-</td><td>concentration, resulting in a vicious cycle 3 .</td></tr><tr><td>dicators of lipid peroxidation and oxidative stress, in</td><td>Melatonin (N-acetyl-5-methoxytryptamine) is the</td></tr><tr><td>which free radicals fulfill the main role in the patho-</td><td>major product of the pineal gland, which functions as</td></tr><tr><td>genesis of these complications.</td><td>a regulator of sleep, circadian rhythm, and immune</td></tr><tr><td>Alloxan-induced diabetes was reported to induce</td><td>function. Melatonin and its metabolites have potent</td></tr><tr><td>oxidative stress and generate reactive oxygen species</td><td>antioxidant/anti-inflammatory properties, which</td></tr><tr><td>(ROS)2 . In the presence of intracellular thiols, espe-</td><td>have proven to be highly effective in a variety of dis-</td></tr><tr><td>cially glutathione, alloxan generates ROS in a cyclic</td><td>orders linked to inflammation and oxidative stress 4,5.</td></tr><tr><td>redox reaction with its reduction product, dialuric</td><td>Melatonin not only neutralizes reactive oxygen spe-</td></tr><tr><td>acid. Autoxidation of dialuric acid generates super-</td><td>cies (ROS), but also acts through the stimulation of</td></tr><tr><td>oxide radicals, hydrogen peroxide and, in the final</td><td>several antioxidative enzymatic systems and stabiliz-</td></tr><tr><td>iron-catalysed reaction step, hydroxyl radicals. These</td><td>ing cell membranes 6 .</td></tr><tr><td>hydroxyl radicals are ultimately responsible for the</td><td>The Cori cycle (Fig. 1), named after its discover-</td></tr><tr><td>death of beta cells, which have a particularly low an-</td><td>ers, Carl Ferdinand Cori and Gerty Cori, refers to</td></tr><tr><td>tioxidative defense capacity, and the ensuing state of</td><td>the metabolic pathway in which lactate produced by</td></tr><tr><td>insulin-dependent ‘alloxan diabetes’.</td><td>anaerobic glycolysis in the muscles moves to the liver</td></tr><tr><td>Diabetes mellitus (DM) is characterized by auto-</td><td>and is converted to glucose, which then returns to</td></tr><tr><td>immunity against pancreatic  cells, resulting in their</td><td>the muscles and is metabolized back to lactate7.</td></tr><tr><td>destruction and the patients’ subsequent depend-</td><td>This cycle of substrate fluxes, simplified as plasma</td></tr><tr><td>ency on lifelong insulin replacement. DM patients</td><td>glucose –-&gt; muscle glycogen –-&gt; plasma lactate –-&gt; liver</td></tr><tr><td>have many complications, including cardiovascular,</td><td>glycogen –-&gt; plasma glucose, is important in the redis-</td></tr><tr><td>renal, and retinal disorders. Among them, skeletal</td><td>tribution of carbohydrate fuels in some species and is</td></tr><tr><td>muscle is a major target tissue of diabetic damage.</td><td>discussed here in relation to the role of melatonin.</td></tr><tr><td>Skeletal muscle is one of the largest organs in the hu-</td><td>Figure 2 presents the substrate contribu-</td></tr><tr><td>man body and is, quantitatively, the most important</td><td>tion to renal gluconeogenesis as measured using</td></tr><tr><td></td><td>June 2019 / 261</td></tr></table></page>
<page number="3">
<table data-filename="06.INFLUENCE OF MELATONIN ON THE ACTIVITY OF MAIN ENZYMES.pdf" data-page="3" data-table="1"><tr><td colspan="3">Influence of melatonin on the activity of main enzymes of cori cycle in skeletal muscles, heart... – KUSHNIR et al</td></tr><tr><td colspan="3">Figure 1. The Cori cycle</td></tr><tr><td colspan="3">Figure 2. The substrate contribution to renal gluconeogenesis.</td></tr><tr><td>arteriovenous renal glucose and substrate balances</td><td colspan="2">The influence of melatonin on the activities of</td></tr><tr><td>together with renal glucose release measurement us-<br/>ing deuterated glucose dilution. According to these</td><td colspan="2">PK and G-6-Phase in skeletal muscles, heart, liver<br/>and kidneys as well as on the content of glycogen in</td></tr><tr><td>data, lactate accounted for approximately 50% of</td><td colspan="2">heart and muscles of alloxan diabetic rats is poorly</td></tr><tr><td>renal gluconeogenesis. It can be calculated that re-</td><td colspan="2">understood. The present study evaluated whether me-</td></tr><tr><td>nal glucose release from lactate is equivalent to 50%</td><td colspan="2">latonin administration would have protective effect</td></tr><tr><td>of overall lactate conversion to glucose. These data</td><td colspan="2">against alloxan-induced changes in the Cori cycle.</td></tr><tr><td>underline the major role of the kidneys in the Cori</td><td></td><td></td></tr><tr><td>cycle. One-half of glucose production within the Cori</td><td colspan="2">THEOBJECTIVE OF THE STUDYwas to determine the</td></tr><tr><td>cycle actually takes place in the kidney 8 .</td><td colspan="2">influence of melatonin on basal levels of glucose (BG)</td></tr><tr><td>Pyruvate- kinase (PK, EC 2.7.1.40) is the enzyme</td><td colspan="2">in blood, activities of G-6-Phase in kidney and liver,</td></tr><tr><td>that catalyzes the final step of glycolysis9.</td><td colspan="2">PK in muscles and heart, content of glycogen in mus-</td></tr><tr><td>Glucose-6-phosphatase (G-6-Phase, EC 3.1.3.9)</td><td colspan="2">cles and heart of alloxan diabetic rats.</td></tr><tr><td>is an enzyme that hydrolyzes glucose 6-phosphate, re-</td><td></td><td></td></tr><tr><td>sulting in the creation of a phosphate group and free</td><td>M ATERIALS</td><td>AND METHODS</td></tr><tr><td>glucose. Glucose is then exported from the cell via</td><td></td><td></td></tr><tr><td>glucose transporter membrane proteins. This cataly-</td><td colspan="2">The research was performed in compliance</td></tr><tr><td>sis completes the final step in gluconeogenesis and</td><td colspan="2">with the Rules of the work using experimental ani-</td></tr><tr><td>therefore plays a key role in the homeostatic regula-</td><td colspan="2">mals (1977) and the Council of Europe Convention</td></tr><tr><td>tion of blood glucose levels10 .</td><td colspan="2">on the Protection of Vertebrate Animals used</td></tr><tr><td>262 / vol. 54, no. 2</td><td></td><td></td></tr></table></page>
<page number="4">
<table data-filename="06.INFLUENCE OF MELATONIN ON THE ACTIVITY OF MAIN ENZYMES.pdf" data-page="4" data-table="1"><tr><td colspan="3">Archives of the Balkan Medical Union</td></tr><tr><td colspan="3">Figure 3. The level of basal glycemia (mmol/l) in blood of rats, (n=6, x±Sx) :</td></tr><tr><td colspan="3">1. a, b, c – changes are reliable (р≤0,05). 2. a – concerning intact rats (control);</td></tr><tr><td colspan="3">b – concerning rats with diabetes mellitus; c – concerning indices on the 4 th day.</td></tr><tr><td>in experiments and other scientific purposes</td><td colspan="2">Statistical analysis was performed using Sta-</td></tr><tr><td>(Strasbourg, 1986), according to directions of</td><td colspan="2">tistica 10 StatSoft Inc. With the purpose of deter-</td></tr><tr><td>International Committee of Medical Journals</td><td colspan="2">mination of an adequate method of statistical esti-</td></tr><tr><td>Editors (ICMJE), as well as “Bioethical expertise of</td><td colspan="2">mation of the average difference between the study</td></tr><tr><td>preclinical and other scientific research conducted</td><td colspan="2">groups, preliminary check of distribution quantities</td></tr><tr><td>on animals“ (Kyiv, 2006). Diabetes was induced in</td><td colspan="2">in samples was held. According to Shapiro-Wilk crite-</td></tr><tr><td>male Wistar rats by single i.p. injection of alloxan</td><td colspan="2">ria, which are used to assess the normality of distribu-</td></tr><tr><td>(170 mg/kg)11 . Four days after diabetes induction,</td><td colspan="2">tion in the sample volume n≤50, all the samples did</td></tr><tr><td>rats were divided into diabetic (DM) and DM +me-</td><td colspan="2">not receive data on deviation of the distribution of</td></tr><tr><td>latonin group (10 mg/kg «Sigma» USA, daily and</td><td colspan="2">samples from normal (P&gt;0.05). Given these data, the</td></tr><tr><td>orally for 14 days starting from the 5 thday). Rats</td><td colspan="2">use of Mann-Whitney test was considered sufficient</td></tr><tr><td>with DM are characterized by BG ≥ 8.0 mmol/L.</td><td colspan="2">for valid conclusions. Differences were considered to</td></tr><tr><td>Blood was taken from the tail vein in the 4 thand</td><td colspan="2">be statistically significant at P≤0.05 14,15.</td></tr><tr><td>19 thday, the BG level was evaluated with the use</td><td></td><td></td></tr><tr><td>of OneTouchUltra (LifeScan, USA). Animals were</td><td>R ESULTS</td><td>AND DISCUSSION</td></tr><tr><td>sacrificed on the19 th day from the beginning of the</td><td></td><td></td></tr><tr><td>experiment, in accordance with the ethical treat-</td><td colspan="2">Uncontrolled insulin-dependent DM leads to</td></tr><tr><td>ment of animals. The rectus femoris muscle tissue,</td><td colspan="2">increased hepatic glucose output (Fig. 3).</td></tr><tr><td>heart, kidney and liver were quickly removed, rinsed</td><td colspan="2">Melatonin injections caused a sharp decrease by</td></tr><tr><td>in saline, blotted, weighed and homogenized. The</td><td colspan="2">52% and normalization (on 19 th day) of the elevated</td></tr><tr><td>homogenate, 5% in ice-cold 0.25 mM tris-HCl-buffer</td><td colspan="2">serum glucose level in DM group of rats compared</td></tr><tr><td>(pH 7.4), was prepared using a homogenizer. The su-</td><td colspan="2">with BG level before treatment. This can be ex-</td></tr><tr><td>pernatant of the homogenate, prepared by ultracen-</td><td colspan="2">plained by that fact that melatonin stimulates glucose</td></tr><tr><td>trifugation for 10 min at 3000g was used for meas-</td><td colspan="2">transport to skeletal muscle cells via insulin recep-</td></tr><tr><td>urement of enzyme activities. Determinations of the</td><td colspan="2">tor substrate-1/ phosphoinositide 3-kinase (IRS-1/</td></tr><tr><td>enzymes activities were defined by standard meth-</td><td colspan="2">PI-3-kinase) pathway, which implies, at the molecular</td></tr><tr><td>ods, concentration was measured by spectrophotom-</td><td colspan="2">level, its role in glucose homeostasis and possibly in</td></tr><tr><td>eter SP-46/ photo colorimeter KFK311 . The splitting</td><td colspan="2">diabetes. Additionally, exposure to light at night and</td></tr><tr><td>of rectus femoris muscle tissue and heart muscle tis-</td><td colspan="2">aging, both of which lower endogenous melatonin</td></tr><tr><td>sue with 30% solution of KOH, followed by the addi-</td><td colspan="2">levels, may contribute to the incidence and/or devel-</td></tr><tr><td>tion of ethanol and cooling, caused the precipitation</td><td colspan="2">opment of diabetes16 .</td></tr><tr><td>of glycogen. Glycogen hydrolyzed by sulfuric acid to</td><td colspan="2">PK is the enzyme that catalyses the final step</td></tr><tr><td>glucose, which is indicated by glycogen content12 .</td><td colspan="2">of glycolysis. It catalyses the transfer of a phosphate</td></tr><tr><td>Total protein determination (according to</td><td colspan="2">group from phosphoenolpyruvate (PEP) to adenosine</td></tr><tr><td>Lowry) was performed according to the process de-</td><td colspan="2">diphosphate (ADP), yielding one molecule of pyru-</td></tr><tr><td>scribed by Gudumac and coauthors11,13 .</td><td colspan="2">vate and one molecule of ATP. According to our</td></tr><tr><td></td><td></td><td>June 2019 / 263</td></tr></table></page>
<page number="5">
<table data-filename="06.INFLUENCE OF MELATONIN ON THE ACTIVITY OF MAIN ENZYMES.pdf" data-page="5" data-table="1"><tr><td colspan="2">Influence of melatonin on the activity of main enzymes of cori cycle in skeletal muscles, heart... – KUSHNIR et al</td></tr><tr><td colspan="2">Figure 4. Pyruvate-kinase, mkmol/min×mg in muscles and heart (n=6, x±Sx):</td></tr><tr><td colspan="2">1. a, b – changes are reliable (р≤0.05). 2. a – concerning control rats;</td></tr><tr><td colspan="2">b – concerning rats with diabetes mellitus.</td></tr><tr><td>results (Fig. 4), the activity of PK in muscle and heart</td><td>glucose release, although only they may indirectly</td></tr><tr><td>tissue of alloxan diabetic animals were 45% and 63%</td><td>affect both hepatic and renal glucose release by in-</td></tr><tr><td>less than in control group. It can be explained by low</td><td>creasing availability of gluconeogenic substrates by</td></tr><tr><td>uptake of glucose from the blood to muscle tissue in</td><td>suppressing insulin secretion.</td></tr><tr><td>the absence of insulin. Insulin stimulates glucose up-</td><td>In accordance to our results (Fig. 5) obtained</td></tr><tr><td>take, in particular in adipose tissue and skeletal mus-</td><td>in kidneys and liver of diabetic rats, the activity of</td></tr><tr><td>cle. This is accomplished by insulin-mediated move-</td><td>G-6-phosphatase was increased in average by 148%</td></tr><tr><td>ment of glucose transporting proteins to the plasma</td><td>compared with control value. Reduced activity of</td></tr><tr><td>membrane of these tissues. Reduced glucose uptake</td><td>G-6-phosphatase in alloxan diabetic rats under me-</td></tr><tr><td>by peripheral tissues in turn leads to a reduced rate</td><td>latonin action, that is demonstrated by our results,</td></tr><tr><td>of glucose metabolism. That means reduction of sub-</td><td>is probably due to the fact that melatonin is in the</td></tr><tr><td>strate for next catabolic changes in glycolysis. In ad-</td><td>physiological counteraction with cortisone. Increased</td></tr><tr><td>dition, the activity of PK is regulated by insulin. We</td><td>concentration of corticosterone and 11-dehydrocor-</td></tr><tr><td>found that the activity of PK was normalized by intro-</td><td>ticosterone was found 20in the serum of rats with</td></tr><tr><td>ducing of melatonin 10 mg/kg of b.w. So, the activity</td><td>alloxan-induced diabetes. Melatonin at a dose of 4</td></tr><tr><td>of PK is reduced during DM, and the administration</td><td>mg/kg inhibited pyridoxal-induced glycogenolysis</td></tr><tr><td>of melatonin leads to increasing its activity, probably</td><td>and reduced hyperglycemia due to reduced levels of</td></tr><tr><td>due to direct activation of gene expression of glucose</td><td></td></tr><tr><td style="text-align: right">17,18</td><td>catecholamines in blood plasma 21.</td></tr><tr><td>transporter GLUT 4, 2, 1  .<br/>The effects of melatonin on insulin secretion</td><td>Thus, melatonin has the potential to regulate</td></tr><tr><td>are mediated through the melatonin receptors (MT1</td><td>glucose homeostasis through decreased gluconeogen-</td></tr><tr><td>and MT2). It decreases insulin secretion by inhibit-</td><td>esis in kidneys and liver of diabetic rats.</td></tr><tr><td>ing cAMP and cGMP pathways, but activates the</td><td>Diabetes may cause myocardial cell damage</td></tr><tr><td>phospholipase C/IP3 pathway, which mobilizes Ca 2+</td><td>and eventually lead to the development of diabetic</td></tr><tr><td>from organelles and, consequently, increases insulin</td><td>cardiomyopathy (DCM). DCM is a disease caused</td></tr><tr><td>secretion. Probably, melatonin enhances the uptake</td><td>by diabetes that is independent of coronary artery</td></tr><tr><td>of glucose to muscles and activates PK activity by in-</td><td>disease, hypertension and heart valve disease. The</td></tr><tr><td>fluencing the insulin secretion or direct19.</td><td>main characteristics of DCM include oxidative stress,</td></tr><tr><td>Some authors describe the fact that the kidneys</td><td>cardiac hypertrophy, apoptosis, myocardial fibrosis</td></tr><tr><td>contribute to glucose homeostasis through the pro-</td><td>and impaired cardiac function12 . Melatonin, a potent</td></tr><tr><td>cesses of gluconeogenesis, glucose filtration, glucose</td><td>antioxidant agent, is essential for glucose homeostasis</td></tr><tr><td>reabsorption, and glucose consumption11.</td><td>and regulation.</td></tr><tr><td>In humans, only liver and kidneys contain signif-</td><td>Therefore, the goal of the present study was to</td></tr><tr><td>icant amounts of the enzyme G-6-Phase and therefore</td><td>investigate the effects of melatonin against DCM</td></tr><tr><td>are the only organs able to perform gluconeogenesis.</td><td>in a rat model of diabetes and its possible mecha-</td></tr><tr><td>Catecholamines normally exert direct effects on renal</td><td>nism.</td></tr><tr><td>264 / vol. 54, no. 2</td><td></td></tr></table></page>
<page number="6">
<table data-filename="06.INFLUENCE OF MELATONIN ON THE ACTIVITY OF MAIN ENZYMES.pdf" data-page="6" data-table="1"><tr><td colspan="2">Archives of the Balkan Medical Union</td></tr><tr><td colspan="2">Figure 5. Glucose-6-phosphatase, mkmol/min×mg (n=6, x±Sx):</td></tr><tr><td colspan="2">1. a, b – changes are reliable (р≤0,05). 2. a – concerning intact rats; b – concerning rats with diabetes mellitus.</td></tr><tr><td colspan="2">Figure 6. Glycogen, mg% (n=6, x±Sx):</td></tr><tr><td colspan="2">1. a, b – changes are reliable (р≤0.05). 2. a – concerning intact rats; b – concerning rats with diabetes mellitus.</td></tr><tr><td>We have established a reduction of glycogen (Fig.</td><td>number of beta-cells decreased by 90%, percentage</td></tr><tr><td>6) in the heart and skeleton muscles of diabetic ani-</td><td>of beta-cells with necrosis was 97% compared respec-</td></tr><tr><td>mals in average by 20% compared with the control.</td><td>tively with the indices of control animals. Melatonin</td></tr><tr><td>Such changes are likely to occur due to a de-</td><td>treatment caused a sharp decrease in the elevated se-</td></tr><tr><td>crease in levels of glucose in heart muscle tissue and</td><td>rum glucose and partial regeneration/proliferation of</td></tr><tr><td>inhibition of its use. According to our research, 2</td><td>beta-cells of islets. It is concluded that the hypoglyce-</td></tr><tr><td>weeks of daily administration of melatonin to diabet-</td><td>mic action of melatonin could be partly due to amelio-</td></tr><tr><td>ic rats at 10 mg/kg of b.w. resulted in normalization</td><td>ration in the beta-cells of pancreatic islets.</td></tr><tr><td>of heart muscle glycogen content. The positive impact</td><td></td></tr><tr><td>of melatonin was probably mediated by improving</td><td>C ONCLUSIONS</td></tr><tr><td>the glucose utilization, due to increased capture of tis-</td><td></td></tr><tr><td>sues and activating major enzymes of glycogenesis22 .</td><td>These findings suggest that melatonin reverses</td></tr><tr><td>The possible link between melatonin and insulin</td><td>the catabolic consequences of total lack of insulin,</td></tr><tr><td>interaction may be in its protective effect against free</td><td>by potentially decreasing of basal glucose level in the</td></tr><tr><td>radical attack of -cells Langerhans islets in pancreas.</td><td>blood, increasing pyruvate-kinase activity and glyco-</td></tr><tr><td>We carried out investigations of Langerhans islets in</td><td>gen content in skeletal and heart muscles and sup-</td></tr><tr><td>our previous studies23. Histomorphological alterations</td><td>pressing the glucose-6-phosphatase activity in liver</td></tr><tr><td>in Langerhans islets of pancreas in diabetic rats were</td><td>and kidneys of alloxan diabetic rats. This restores the</td></tr><tr><td>recorded: their share decreased reliably by 55%, the</td><td>events in Cori cycle by possible activation of glycolysis</td></tr><tr><td></td><td>June 2019 / 265</td></tr></table></page>
<page number="7">
<table data-filename="06.INFLUENCE OF MELATONIN ON THE ACTIVITY OF MAIN ENZYMES.pdf" data-page="7" data-table="1"><tr><td colspan="3">Influence of melatonin on the activity of main enzymes of cori cycle in skeletal muscles, heart... – KUSHNIR et al</td></tr><tr><td colspan="2">and glycogenesis in skeletal and heart muscles and</td><td>9. Gupta V, Bamezai RN. Human pyruvate kinase M2: a mul-</td></tr><tr><td colspan="2">causes normalization of gluconeogenesis in liver and</td><td>tifunctional protein. Protein Science. 2010; 19(11):2031–44.</td></tr><tr><td></td><td></td><td>10. Ghosh A, Shieh JJ, Pan CJ, Sun MS, Chou JY. The catalytic</td></tr><tr><td colspan="2">kidneys.</td><td>center of glucose-6-phosphatase. HIS176 is the nucleophile</td></tr><tr><td></td><td></td><td>forming the phosphohistidine-enzyme intermediate dur-</td></tr><tr><td></td><td></td><td>ing catalysis. The Journal of Biological Chemistry. 2002;277</td></tr><tr><td colspan="2">Compliance with Ethics Requirements:</td><td>(36):32837–42.</td></tr><tr><td></td><td>„The authors declare no conflict of interest regarding</td><td>11. Kushnir OYu, Yaremii IM, Shvetsv VI, Shvets NV. Influence</td></tr><tr><td colspan="2">this article“</td><td>of melatonin on carbohydrate metabolism in the kidneys of</td></tr><tr><td></td><td></td><td>alloxan diabetic rats. Fiziol. Journ. 2017;63(4):64 – 71.</td></tr><tr><td></td><td>„The authors declare that all the procedures and ex-</td><td>12. Heather R. Cross, Lionel H. Opie, George K. Radda, Kieran</td></tr><tr><td colspan="2">periments of this study respect the Rules of the work using</td><td>Clarke. Is a high glycogen content beneficial or detrimental</td></tr><tr><td colspan="2">experimental animals (1977) and the Council of Europe</td><td>to the ischemic rat heart? Circulation Research. 1996;78:482–</td></tr><tr><td colspan="2">Convention on the Protection of Vertebrate Animals used</td><td style="text-align: right">491.</td></tr><tr><td colspan="2">in experiments and other scientific purposes (Strasbourg,</td><td>13. Ceban E, Banov P, Galescu A, Botnari V. Oxidative stress</td></tr><tr><td></td><td></td><td>and antioxidant status in patients with complicated urolithi-</td></tr><tr><td colspan="2">1986), according to directions of International Committee</td><td>asis. J Med Life. 2016;9(3):259–262.</td></tr><tr><td colspan="2">of Medical Journals Editors (ICMJE), as well as “Bioethical</td><td>14. Singh J, Kakkar P. Antihyperglycemic and antioxidant effect</td></tr><tr><td colspan="2">expertise of preclinical and other scientific research conduct-</td><td>of Berberis aristata root extract and its role in regulating</td></tr><tr><td colspan="2">ed on animals“ (Kyiv, 2006). “</td><td>carbohydrate metabolism in diabetic rats. J Ethnopharmacol.</td></tr><tr><td></td><td></td><td>2009;123(1):22-26.</td></tr><tr><td></td><td></td><td>15. Vlasova SN, Shabunina EI, Pereslegina IA. The activity of</td></tr><tr><td></td><td></td><td>glutathione-dependent enzymes of erythrocytes in chronic</td></tr><tr><td colspan="2">R EFERENCES</td><td>liver diseases in children. Laboratory Matter. 1990;8:19-21.</td></tr><tr><td></td><td></td><td>16. Pantsiuk K, Kushnir O. Changes of pyruvate kinase activ-</td></tr><tr><td style="text-align: right">1.</td><td>Rahimi-Madiseh M, Malekpour-Tehrani A, Bahmani M,</td><td>ity in the muscle tissue of rats under conditions of alloxan</td></tr><tr><td></td><td>Rafieian-Kopaei M. The research and development on the</td><td>diabetes and administration of melatonin. Przeglad Lekarski.</td></tr><tr><td></td><td>antioxidants in prevention of diabetic complications. Asian</td><td>2017; 74(1):107.</td></tr><tr><td></td><td>Pac J Trop Med. 2016; 9(9):825-831.</td><td>17. Pantsiuk K, Kushnir O. Influence of melatonin on the activ-</td></tr><tr><td style="text-align: right">2.</td><td>Lenzen S. The mechanisms of alloxan- and streptozo-</td><td>ity of glucose-6-phosphatase activity in kidneys of alloxan</td></tr><tr><td></td><td>tocin-induced diabetes. Diabetologia. 2008; 51(2):216-226.</td><td>diabetic rats. Abstract book of International Student Congress</td></tr><tr><td style="text-align: right">3.</td><td>Tang L, Li N, Jian W, Kang Y, Yin B, Sun S, Guo J, Sun L,</td><td>(May 31st – June 2 nd , 2018 Graz, Austria). 2018;96.</td></tr><tr><td></td><td>Ta D. Low-intensity pulsed ultrasound prevents muscle at-</td><td>18. Lin GJ, Huang SH, Chen YW, et al. Melatonin prolongs</td></tr><tr><td></td><td>rophy induced by type 1 diabetes in rats. Skelet Muscle. 2017;</td><td>islet graft survival in diabetic NOD mice. J Pineal Res. 2009;</td></tr><tr><td></td><td>7(1):29.</td><td>47(3):284-292.</td></tr><tr><td style="text-align: right">4.</td><td>Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A re-</td><td>19. Selyatitskaya VG, Cherkasova OP, Pankina TV, Palchikova</td></tr><tr><td></td><td>view of the multiple actions of melatonin on the immune</td><td>NA. Functional state of adrenocortical system in rats with</td></tr><tr><td></td><td>system. Endocrine. 2005; 27(2):189–200.</td><td>manifest alloxan-induced diabetes mellitus. Bull Exp Biol</td></tr><tr><td style="text-align: right">5.</td><td>Mayo JC, Sainz RM, Tan DX, et al. Anti-inflammatory</td><td>Med. 2008; 146(6):708-710.</td></tr><tr><td></td><td>actions of melatonin and it s met abolites,</td><td>20. Budhram R, Lau-Cam CA. Attenuating effect of melatonin</td></tr><tr><td></td><td>N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and</td><td>on pyridoxal-stimulated release of adrenomedullary catecho-</td></tr><tr><td></td><td>N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J</td><td>lamines in the rat. Life Sciences. 2009;84(19-20):696-704.</td></tr><tr><td></td><td>Neuroimmunol. 2005;165(1-2):139–149.</td><td>21. Ha E, Yim SV, Chung JH, et al. Melatonin stimulates glucose</td></tr><tr><td style="text-align: right">6.</td><td>Rodriguez C, Mayo JC, Sainz RM, et al. Regulation of an-</td><td>transport via insulin receptor substrate-1/phosphatidylinosi-</td></tr><tr><td></td><td>tioxidant enzymes: a significant role for melatonin. J Pineal</td><td>tol 3-kinase pathway in C2C12 murine skeletal muscle cells.</td></tr><tr><td></td><td>Res. 2004;36(1):1–9.</td><td>J Pineal Res. 2006;41(1):67-72.</td></tr><tr><td style="text-align: right">7.</td><td>Nelson DL, Cox MM. Lehninger: Principles of Biochemistry,</td><td>22. Peschke E, Stumpf I, Bazwinsky I, Litvak L, Dralle H,</td></tr><tr><td></td><td>Fourth Edition. New York, W.H. Freeman and Company,</td><td>Mühlbauer E. Melatonin and type 2 diabetes – a possible</td></tr><tr><td></td><td>2005: 340.</td><td>link? J Pineal Res. 2007;42(4):350-8.</td></tr><tr><td style="text-align: right">8.</td><td>Cano N. Bench-to-bedside review: Glucose production from</td><td>23. Kushnir A, Davydenko I. Influence of melatonin on con-</td></tr><tr><td></td><td>the kidneys. Crit Care. 2002;6(4):317–321.</td><td>dition of the Langerhans islets of the pancreas in alloxan</td></tr><tr><td></td><td></td><td>diabetic rats. World of Medicine and Biology. 2009; 5(4):31-35.</td></tr><tr><td colspan="2">266 / vol. 54, no. 2</td><td></td></tr></table></page>
</document>
